Relationship of c-erbB-2 expression to clinicopathological features and prognosis in gastric cancer

被引:0
|
作者
Karayiannakis, AJ [1 ]
Syrigos, KN [1 ]
Chatzigianni, E [1 ]
Valinos, P [1 ]
Bousiakos, P [1 ]
Balas, G [1 ]
Lakiotis, G [1 ]
Simatos, G [1 ]
机构
[1] IKA Hosp 1, Dept Surg 1, Athens, Greece
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, the expression of c-erbB-2 was investigated immunohistochemically in 61 formalin-fixed, paraffin-embedded specimens of gastric carcinoma. Membranous c-erbB-2 immunoreactivity was observed in 36% of tumours. Intestinal type tumours had a significantly higher incidence of c-erbB-2 expression than did diffuse type tumours. c-erbB-2 expression correlated with serosal invasion, lymph node metastasis and advanced tumour stage compared with c-erbB-2 negative tumours. Survival rates of patients with c-erbB-2 positive carcinomas were significantly lower than those with c-erbB-2 negative carcinomas. These findings suggest that erbB-2 expression is associated with an aggressive phenotype and poor prognosis in gastric cancer.
引用
收藏
页码:269 / 272
页数:4
相关论文
共 50 条
  • [1] The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer
    Gürel, S
    Dolar, E
    Yerci, Ö
    Samli, B
    Öztürk, H
    Nak, SG
    Gülten, M
    Memik, F
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1999, 27 (02) : 74 - 78
  • [2] Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer
    Shun, CT
    Wu, MS
    Lin, JT
    Chen, SY
    Wang, HP
    Lee, WJ
    Wang, TH
    Chuang, SM
    HEPATO-GASTROENTEROLOGY, 1997, 44 (14) : 604 - 609
  • [3] c-erbB-2 expression and prognosis of gastric cancer: a meta-analysis
    Wang, Z. Q.
    Sun, B. J.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (01) : 1782 - 1787
  • [4] GASTRIC-CANCER - CLINICOPATHOLOGICAL CHARACTERISTICS AND EXPRESSION OF C-ERBB-2 IN 122 CASES
    ORTOLANI, MC
    SUNDBLAD, AS
    MEDICINA-BUENOS AIRES, 1993, 53 (02) : 97 - 102
  • [5] Membranous levels of c-erbB-2 oncoprotein in gastric cancer:: Their relationship with clinicopathological parameters and their prognostic significance
    Vizoso, FJ
    Corte, MD
    Alvarez, A
    García, I
    del Casar, JM
    Bongera, M
    González, LO
    García-Muñiz, JL
    Allende, MT
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2004, 19 (04): : 268 - 274
  • [6] Overexpression of EGFR and c-erbB-2 associated with clinicopathological factors in gastric cancer
    Nakajima, M
    Hirao, T
    Miwa, T
    Sakaguchi, T
    Matsuda, M
    Tatsumi, M
    Yamada, T
    Yamada, Y
    Sawada, H
    Watanabe, A
    Nakano, H
    RECENT ADVANCES IN GASTROENTEROLOGICAL CARCINOGENESIS I, 1996, : 405 - 409
  • [7] C-ERBB-2 ONCOGENE PRODUCT EXPRESSION AND PROGNOSIS IN GASTRIC-CARCINOMA
    HILTON, DA
    WEST, KP
    JOURNAL OF PATHOLOGY, 1990, 161 (04): : A356 - A356
  • [8] C-ERBB-2 ONCOGENE PRODUCT EXPRESSION AND PROGNOSIS IN GASTRIC-CARCINOMA
    HILTON, DA
    WEST, KP
    JOURNAL OF CLINICAL PATHOLOGY, 1992, 45 (05) : 454 - 456
  • [9] CLINICOPATHOLOGICAL SIGNIFICANCE OF C-ERBB-2 PROTEIN EXPRESSION IN HUMAN GASTRIC-CARCINOMA
    TATEISHI, M
    TODA, T
    MINAMISONO, Y
    NAGASAKI, S
    JOURNAL OF SURGICAL ONCOLOGY, 1992, 49 (04) : 209 - 212
  • [10] Altered expression of β-catenin and c-erbB-2 in early gastric cancer
    Ougolkov, A
    Mai, M
    Takahashi, Y
    Omote, K
    Bilim, V
    Shimizu, A
    Minamoto, T
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2000, 19 (03): : 349 - 355